DK170283B1 - Ascorbat-2-polyphosphatforbindelser og fremgangsmåde til deres fremstilling - Google Patents
Ascorbat-2-polyphosphatforbindelser og fremgangsmåde til deres fremstilling Download PDFInfo
- Publication number
- DK170283B1 DK170283B1 DK092987A DK92987A DK170283B1 DK 170283 B1 DK170283 B1 DK 170283B1 DK 092987 A DK092987 A DK 092987A DK 92987 A DK92987 A DK 92987A DK 170283 B1 DK170283 B1 DK 170283B1
- Authority
- DK
- Denmark
- Prior art keywords
- ascorbate
- ascorbic acid
- reaction
- astp
- reaction mixture
- Prior art date
Links
- 150000001875 compounds Chemical class 0.000 title claims description 18
- 238000000034 method Methods 0.000 title claims description 16
- 229920000388 Polyphosphate Polymers 0.000 title claims description 13
- 239000001205 polyphosphate Substances 0.000 title claims description 13
- 235000011176 polyphosphates Nutrition 0.000 title claims description 10
- 238000002360 preparation method Methods 0.000 title claims description 6
- 238000006243 chemical reaction Methods 0.000 claims description 37
- 229910052739 hydrogen Inorganic materials 0.000 claims description 13
- 150000003839 salts Chemical class 0.000 claims description 11
- 239000001257 hydrogen Substances 0.000 claims description 10
- 239000001226 triphosphate Substances 0.000 claims description 10
- MIJPAVRNWPDMOR-ZAFYKAAXSA-N L-ascorbic acid 2-phosphate Chemical class OC[C@H](O)[C@H]1OC(=O)C(OP(O)(O)=O)=C1O MIJPAVRNWPDMOR-ZAFYKAAXSA-N 0.000 claims description 9
- 239000002585 base Substances 0.000 claims description 9
- UEZVMMHDMIWARA-UHFFFAOYSA-N Metaphosphoric acid Chemical compound OP(=O)=O UEZVMMHDMIWARA-UHFFFAOYSA-N 0.000 claims description 8
- 239000000243 solution Substances 0.000 claims description 8
- UFHFLCQGNIYNRP-UHFFFAOYSA-N Hydrogen Chemical compound [H][H] UFHFLCQGNIYNRP-UHFFFAOYSA-N 0.000 claims description 7
- DGAQECJNVWCQMB-PUAWFVPOSA-M Ilexoside XXIX Chemical group C[C@@H]1CC[C@@]2(CC[C@@]3(C(=CC[C@H]4[C@]3(CC[C@@H]5[C@@]4(CC[C@@H](C5(C)C)OS(=O)(=O)[O-])C)C)[C@@H]2[C@]1(C)O)C)C(=O)O[C@H]6[C@@H]([C@H]([C@@H]([C@H](O6)CO)O)O)O.[Na+] DGAQECJNVWCQMB-PUAWFVPOSA-M 0.000 claims description 7
- 229910052708 sodium Inorganic materials 0.000 claims description 6
- 239000011734 sodium Substances 0.000 claims description 6
- 229910052783 alkali metal Inorganic materials 0.000 claims description 5
- 150000001768 cations Chemical class 0.000 claims description 5
- LMBFAGIMSUYTBN-MPZNNTNKSA-N teixobactin Chemical compound C([C@H](C(=O)N[C@@H]([C@@H](C)CC)C(=O)N[C@@H](CO)C(=O)N[C@H](CCC(N)=O)C(=O)N[C@H]([C@@H](C)CC)C(=O)N[C@@H]([C@@H](C)CC)C(=O)N[C@@H](CO)C(=O)N[C@H]1C(N[C@@H](C)C(=O)N[C@@H](C[C@@H]2NC(=N)NC2)C(=O)N[C@H](C(=O)O[C@H]1C)[C@@H](C)CC)=O)NC)C1=CC=CC=C1 LMBFAGIMSUYTBN-MPZNNTNKSA-N 0.000 claims description 5
- 150000001340 alkali metals Chemical class 0.000 claims description 4
- 125000002887 hydroxy group Chemical group [H]O* 0.000 claims description 3
- 239000007864 aqueous solution Substances 0.000 claims description 2
- 125000006239 protecting group Chemical group 0.000 claims description 2
- 150000003512 tertiary amines Chemical class 0.000 claims description 2
- SUZJDLRVEPUNJG-UHFFFAOYSA-K tripotassium 2,4,6-trioxido-1,3,5,2lambda5,4lambda5,6lambda5-trioxatriphosphinane 2,4,6-trioxide Chemical compound [K+].[K+].[K+].[O-]P1(=O)OP([O-])(=O)OP([O-])(=O)O1 SUZJDLRVEPUNJG-UHFFFAOYSA-K 0.000 claims description 2
- YZCKVEUIGOORGS-OUBTZVSYSA-N Deuterium Chemical compound [2H] YZCKVEUIGOORGS-OUBTZVSYSA-N 0.000 claims 1
- CIWBSHSKHKDKBQ-JLAZNSOCSA-N Ascorbic acid Chemical compound OC[C@H](O)[C@H]1OC(=O)C(O)=C1O CIWBSHSKHKDKBQ-JLAZNSOCSA-N 0.000 description 201
- 229960005070 ascorbic acid Drugs 0.000 description 57
- 239000002211 L-ascorbic acid Substances 0.000 description 41
- 235000000069 L-ascorbic acid Nutrition 0.000 description 40
- 239000011541 reaction mixture Substances 0.000 description 38
- 235000010323 ascorbic acid Nutrition 0.000 description 24
- ZZZCUOFIHGPKAK-UHFFFAOYSA-N D-erythro-ascorbic acid Natural products OCC1OC(=O)C(O)=C1O ZZZCUOFIHGPKAK-UHFFFAOYSA-N 0.000 description 22
- 229930003268 Vitamin C Natural products 0.000 description 22
- 239000011668 ascorbic acid Substances 0.000 description 22
- 235000019154 vitamin C Nutrition 0.000 description 22
- 239000011718 vitamin C Substances 0.000 description 22
- 241001465754 Metazoa Species 0.000 description 20
- KWYUFKZDYYNOTN-UHFFFAOYSA-M potassium hydroxide Inorganic materials [OH-].[K+] KWYUFKZDYYNOTN-UHFFFAOYSA-M 0.000 description 17
- 235000013305 food Nutrition 0.000 description 16
- 238000010521 absorption reaction Methods 0.000 description 14
- 239000000203 mixture Substances 0.000 description 14
- 102000004160 Phosphoric Monoester Hydrolases Human genes 0.000 description 13
- 108090000608 Phosphoric Monoester Hydrolases Proteins 0.000 description 13
- CIWBSHSKHKDKBQ-DUZGATOHSA-N D-isoascorbic acid Chemical compound OC[C@@H](O)[C@H]1OC(=O)C(O)=C1O CIWBSHSKHKDKBQ-DUZGATOHSA-N 0.000 description 12
- HEMHJVSKTPXQMS-UHFFFAOYSA-M Sodium hydroxide Chemical compound [OH-].[Na+] HEMHJVSKTPXQMS-UHFFFAOYSA-M 0.000 description 12
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 description 12
- SUQVNMZSSKXYRH-ZAFYKAAXSA-N [(2r)-2-[(1s)-1,2-dihydroxyethyl]-3-hydroxy-5-oxo-2h-furan-4-yl] [hydroxy(phosphonooxy)phosphoryl] hydrogen phosphate Chemical compound OC[C@H](O)[C@H]1OC(=O)C(OP(O)(=O)OP(O)(=O)OP(O)(O)=O)=C1O SUQVNMZSSKXYRH-ZAFYKAAXSA-N 0.000 description 11
- -1 especially in heat Substances 0.000 description 11
- 230000000694 effects Effects 0.000 description 9
- 150000002148 esters Chemical class 0.000 description 9
- ZCYVEMRRCGMTRW-UHFFFAOYSA-N 7553-56-2 Chemical compound [I] ZCYVEMRRCGMTRW-UHFFFAOYSA-N 0.000 description 8
- MHAJPDPJQMAIIY-UHFFFAOYSA-N Hydrogen peroxide Chemical compound OO MHAJPDPJQMAIIY-UHFFFAOYSA-N 0.000 description 8
- 229910019142 PO4 Inorganic materials 0.000 description 8
- 239000011630 iodine Substances 0.000 description 8
- 229910052740 iodine Inorganic materials 0.000 description 8
- 239000010452 phosphate Substances 0.000 description 8
- 230000035484 reaction time Effects 0.000 description 8
- 238000004448 titration Methods 0.000 description 8
- 241000700198 Cavia Species 0.000 description 7
- 230000002378 acidificating effect Effects 0.000 description 7
- 125000005341 metaphosphate group Chemical group 0.000 description 7
- 238000006366 phosphorylation reaction Methods 0.000 description 7
- NWUYHJFMYQTDRP-UHFFFAOYSA-N 1,2-bis(ethenyl)benzene;1-ethenyl-2-ethylbenzene;styrene Chemical compound C=CC1=CC=CC=C1.CCC1=CC=CC=C1C=C.C=CC1=CC=CC=C1C=C NWUYHJFMYQTDRP-UHFFFAOYSA-N 0.000 description 6
- ZKHQWZAMYRWXGA-KQYNXXCUSA-J ATP(4-) Chemical compound C1=NC=2C(N)=NC=NC=2N1[C@@H]1O[C@H](COP([O-])(=O)OP([O-])(=O)OP([O-])([O-])=O)[C@@H](O)[C@H]1O ZKHQWZAMYRWXGA-KQYNXXCUSA-J 0.000 description 6
- ZKHQWZAMYRWXGA-UHFFFAOYSA-N Adenosine triphosphate Natural products C1=NC=2C(N)=NC=NC=2N1C1OC(COP(O)(=O)OP(O)(=O)OP(O)(O)=O)C(O)C1O ZKHQWZAMYRWXGA-UHFFFAOYSA-N 0.000 description 6
- 238000004458 analytical method Methods 0.000 description 6
- 229940072107 ascorbate Drugs 0.000 description 6
- 239000003729 cation exchange resin Substances 0.000 description 6
- 239000003153 chemical reaction reagent Substances 0.000 description 6
- 235000021317 phosphate Nutrition 0.000 description 6
- 239000000047 product Substances 0.000 description 6
- ATRRKUHOCOJYRX-UHFFFAOYSA-N Ammonium bicarbonate Chemical compound [NH4+].OC([O-])=O ATRRKUHOCOJYRX-UHFFFAOYSA-N 0.000 description 5
- 229910000013 Ammonium bicarbonate Inorganic materials 0.000 description 5
- 150000000996 L-ascorbic acids Chemical class 0.000 description 5
- 235000012538 ammonium bicarbonate Nutrition 0.000 description 5
- 239000001099 ammonium carbonate Substances 0.000 description 5
- 239000006227 byproduct Substances 0.000 description 5
- 239000013078 crystal Substances 0.000 description 5
- 230000003647 oxidation Effects 0.000 description 5
- 238000007254 oxidation reaction Methods 0.000 description 5
- 239000000376 reactant Substances 0.000 description 5
- 239000007858 starting material Substances 0.000 description 5
- IJGRMHOSHXDMSA-UHFFFAOYSA-N Atomic nitrogen Chemical compound N#N IJGRMHOSHXDMSA-UHFFFAOYSA-N 0.000 description 4
- 241000209140 Triticum Species 0.000 description 4
- 235000021307 Triticum Nutrition 0.000 description 4
- 229910052784 alkaline earth metal Inorganic materials 0.000 description 4
- 125000004432 carbon atom Chemical group C* 0.000 description 4
- 238000004440 column chromatography Methods 0.000 description 4
- AZSFNUJOCKMOGB-UHFFFAOYSA-K cyclotriphosphate(3-) Chemical compound [O-]P1(=O)OP([O-])(=O)OP([O-])(=O)O1 AZSFNUJOCKMOGB-UHFFFAOYSA-K 0.000 description 4
- 230000007071 enzymatic hydrolysis Effects 0.000 description 4
- 238000006047 enzymatic hydrolysis reaction Methods 0.000 description 4
- 238000002474 experimental method Methods 0.000 description 4
- 235000013312 flour Nutrition 0.000 description 4
- 229910052816 inorganic phosphate Inorganic materials 0.000 description 4
- NBIIXXVUZAFLBC-UHFFFAOYSA-K phosphate Chemical compound [O-]P([O-])([O-])=O NBIIXXVUZAFLBC-UHFFFAOYSA-K 0.000 description 4
- 229940088594 vitamin Drugs 0.000 description 4
- 229930003231 vitamin Natural products 0.000 description 4
- 235000013343 vitamin Nutrition 0.000 description 4
- 239000011782 vitamin Substances 0.000 description 4
- 150000003722 vitamin derivatives Chemical class 0.000 description 4
- 102000004190 Enzymes Human genes 0.000 description 3
- 108090000790 Enzymes Proteins 0.000 description 3
- DFJLOQHIFSBONA-ZAFYKAAXSA-N [(2r)-2-[(1s)-1,2-dihydroxyethyl]-3-hydroxy-5-oxo-2h-furan-4-yl] phosphono hydrogen phosphate Chemical compound OC[C@H](O)[C@H]1OC(=O)C(OP(O)(=O)OP(O)(O)=O)=C1O DFJLOQHIFSBONA-ZAFYKAAXSA-N 0.000 description 3
- 239000002253 acid Substances 0.000 description 3
- 150000003863 ammonium salts Chemical class 0.000 description 3
- QVGXLLKOCUKJST-UHFFFAOYSA-N atomic oxygen Chemical compound [O] QVGXLLKOCUKJST-UHFFFAOYSA-N 0.000 description 3
- 239000007795 chemical reaction product Substances 0.000 description 3
- 239000003795 chemical substances by application Substances 0.000 description 3
- 235000005911 diet Nutrition 0.000 description 3
- 230000037213 diet Effects 0.000 description 3
- 238000010828 elution Methods 0.000 description 3
- 150000002431 hydrogen Chemical class 0.000 description 3
- 230000001590 oxidative effect Effects 0.000 description 3
- 229910052760 oxygen Inorganic materials 0.000 description 3
- 239000001301 oxygen Substances 0.000 description 3
- 125000002467 phosphate group Chemical group [H]OP(=O)(O[H])O[*] 0.000 description 3
- 229910052698 phosphorus Inorganic materials 0.000 description 3
- 238000000746 purification Methods 0.000 description 3
- UGTZMIPZNRIWHX-UHFFFAOYSA-K sodium trimetaphosphate Chemical compound [Na+].[Na+].[Na+].[O-]P1(=O)OP([O-])(=O)OP([O-])(=O)O1 UGTZMIPZNRIWHX-UHFFFAOYSA-K 0.000 description 3
- 239000007787 solid Substances 0.000 description 3
- 238000003756 stirring Methods 0.000 description 3
- 238000003860 storage Methods 0.000 description 3
- 238000004809 thin layer chromatography Methods 0.000 description 3
- POXUQBFHDHCZAD-UHFFFAOYSA-N 2-(2,2-dimethyl-1,3-dioxolan-4-yl)-3,4-dihydroxy-2h-furan-5-one Chemical compound O1C(C)(C)OCC1C1C(O)=C(O)C(=O)O1 POXUQBFHDHCZAD-UHFFFAOYSA-N 0.000 description 2
- CSCPPACGZOOCGX-UHFFFAOYSA-N Acetone Chemical compound CC(C)=O CSCPPACGZOOCGX-UHFFFAOYSA-N 0.000 description 2
- OKTJSMMVPCPJKN-UHFFFAOYSA-N Carbon Chemical compound [C] OKTJSMMVPCPJKN-UHFFFAOYSA-N 0.000 description 2
- 241000700199 Cavia porcellus Species 0.000 description 2
- 241000282693 Cercopithecidae Species 0.000 description 2
- LFQSCWFLJHTTHZ-UHFFFAOYSA-N Ethanol Chemical compound CCO LFQSCWFLJHTTHZ-UHFFFAOYSA-N 0.000 description 2
- VEXZGXHMUGYJMC-UHFFFAOYSA-N Hydrochloric acid Chemical compound Cl VEXZGXHMUGYJMC-UHFFFAOYSA-N 0.000 description 2
- XEEYBQQBJWHFJM-UHFFFAOYSA-N Iron Chemical compound [Fe] XEEYBQQBJWHFJM-UHFFFAOYSA-N 0.000 description 2
- KFZMGEQAYNKOFK-UHFFFAOYSA-N Isopropanol Chemical compound CC(C)O KFZMGEQAYNKOFK-UHFFFAOYSA-N 0.000 description 2
- 102000045595 Phosphoprotein Phosphatases Human genes 0.000 description 2
- 108700019535 Phosphoprotein Phosphatases Proteins 0.000 description 2
- NBIIXXVUZAFLBC-UHFFFAOYSA-N Phosphoric acid Chemical compound OP(O)(O)=O NBIIXXVUZAFLBC-UHFFFAOYSA-N 0.000 description 2
- JUJWROOIHBZHMG-UHFFFAOYSA-N Pyridine Chemical compound C1=CC=NC=C1 JUJWROOIHBZHMG-UHFFFAOYSA-N 0.000 description 2
- CDBYLPFSWZWCQE-UHFFFAOYSA-L Sodium Carbonate Chemical compound [Na+].[Na+].[O-]C([O-])=O CDBYLPFSWZWCQE-UHFFFAOYSA-L 0.000 description 2
- 244000061456 Solanum tuberosum Species 0.000 description 2
- 235000002595 Solanum tuberosum Nutrition 0.000 description 2
- 239000007983 Tris buffer Substances 0.000 description 2
- DHKHKXVYLBGOIT-UHFFFAOYSA-N acetaldehyde Diethyl Acetal Natural products CCOC(C)OCC DHKHKXVYLBGOIT-UHFFFAOYSA-N 0.000 description 2
- 125000002777 acetyl group Chemical class [H]C([H])([H])C(*)=O 0.000 description 2
- OIRDTQYFTABQOQ-KQYNXXCUSA-N adenosine Chemical compound C1=NC=2C(N)=NC=NC=2N1[C@@H]1O[C@H](CO)[C@@H](O)[C@H]1O OIRDTQYFTABQOQ-KQYNXXCUSA-N 0.000 description 2
- 150000001342 alkaline earth metals Chemical class 0.000 description 2
- 125000000217 alkyl group Chemical group 0.000 description 2
- 239000003957 anion exchange resin Substances 0.000 description 2
- 230000015572 biosynthetic process Effects 0.000 description 2
- 230000037396 body weight Effects 0.000 description 2
- 239000000872 buffer Substances 0.000 description 2
- 150000001720 carbohydrates Chemical class 0.000 description 2
- 229910052799 carbon Inorganic materials 0.000 description 2
- 230000006378 damage Effects 0.000 description 2
- 230000007423 decrease Effects 0.000 description 2
- 238000005538 encapsulation Methods 0.000 description 2
- 238000001914 filtration Methods 0.000 description 2
- HYBBIBNJHNGZAN-UHFFFAOYSA-N furfural Chemical compound O=CC1=CC=CO1 HYBBIBNJHNGZAN-UHFFFAOYSA-N 0.000 description 2
- 210000001035 gastrointestinal tract Anatomy 0.000 description 2
- 229940005740 hexametaphosphate Drugs 0.000 description 2
- 230000007062 hydrolysis Effects 0.000 description 2
- 238000006460 hydrolysis reaction Methods 0.000 description 2
- 230000003301 hydrolyzing effect Effects 0.000 description 2
- ZXEKIIBDNHEJCQ-UHFFFAOYSA-N isobutanol Chemical compound CC(C)CO ZXEKIIBDNHEJCQ-UHFFFAOYSA-N 0.000 description 2
- 238000002955 isolation Methods 0.000 description 2
- 230000008018 melting Effects 0.000 description 2
- 238000002844 melting Methods 0.000 description 2
- 150000004712 monophosphates Chemical group 0.000 description 2
- 229910052757 nitrogen Inorganic materials 0.000 description 2
- 235000015097 nutrients Nutrition 0.000 description 2
- 239000002245 particle Substances 0.000 description 2
- 150000003013 phosphoric acid derivatives Chemical class 0.000 description 2
- 150000003014 phosphoric acid esters Chemical class 0.000 description 2
- XHXFXVLFKHQFAL-UHFFFAOYSA-N phosphoryl trichloride Chemical compound ClP(Cl)(Cl)=O XHXFXVLFKHQFAL-UHFFFAOYSA-N 0.000 description 2
- 230000026731 phosphorylation Effects 0.000 description 2
- 230000000865 phosphorylative effect Effects 0.000 description 2
- 239000011347 resin Substances 0.000 description 2
- 229920005989 resin Polymers 0.000 description 2
- 238000001228 spectrum Methods 0.000 description 2
- 239000000126 substance Chemical group 0.000 description 2
- 238000006467 substitution reaction Methods 0.000 description 2
- 238000012360 testing method Methods 0.000 description 2
- YNJBWRMUSHSURL-UHFFFAOYSA-N trichloroacetic acid Chemical compound OC(=O)C(Cl)(Cl)Cl YNJBWRMUSHSURL-UHFFFAOYSA-N 0.000 description 2
- LENZDBCJOHFCAS-UHFFFAOYSA-N tris Chemical compound OCC(N)(CO)CO LENZDBCJOHFCAS-UHFFFAOYSA-N 0.000 description 2
- SWTGJCNCBUCXSS-ISUZDFFFSA-N (2r)-3,4-dihydroxy-2-[(4s)-2-phenyl-1,3-dioxolan-4-yl]-2h-furan-5-one Chemical compound OC1=C(O)C(=O)O[C@@H]1[C@H]1OC(C=2C=CC=CC=2)OC1 SWTGJCNCBUCXSS-ISUZDFFFSA-N 0.000 description 1
- GZCWLCBFPRFLKL-UHFFFAOYSA-N 1-prop-2-ynoxypropan-2-ol Chemical compound CC(O)COCC#C GZCWLCBFPRFLKL-UHFFFAOYSA-N 0.000 description 1
- CCBICDLNWJRFPO-UHFFFAOYSA-N 2,6-dichloroindophenol Chemical compound C1=CC(O)=CC=C1N=C1C=C(Cl)C(=O)C(Cl)=C1 CCBICDLNWJRFPO-UHFFFAOYSA-N 0.000 description 1
- 102000013563 Acid Phosphatase Human genes 0.000 description 1
- 108010051457 Acid Phosphatase Proteins 0.000 description 1
- 241000251468 Actinopterygii Species 0.000 description 1
- VHUUQVKOLVNVRT-UHFFFAOYSA-N Ammonium hydroxide Chemical compound [NH4+].[OH-] VHUUQVKOLVNVRT-UHFFFAOYSA-N 0.000 description 1
- 208000006770 Ascorbic Acid Deficiency Diseases 0.000 description 1
- BVKZGUZCCUSVTD-UHFFFAOYSA-M Bicarbonate Chemical group OC([O-])=O BVKZGUZCCUSVTD-UHFFFAOYSA-M 0.000 description 1
- 239000002126 C01EB10 - Adenosine Substances 0.000 description 1
- RYGMFSIKBFXOCR-UHFFFAOYSA-N Copper Chemical compound [Cu] RYGMFSIKBFXOCR-UHFFFAOYSA-N 0.000 description 1
- 241000238424 Crustacea Species 0.000 description 1
- WSFSSNUMVMOOMR-UHFFFAOYSA-N Formaldehyde Chemical compound O=C WSFSSNUMVMOOMR-UHFFFAOYSA-N 0.000 description 1
- 102100030509 Histidine protein methyltransferase 1 homolog Human genes 0.000 description 1
- 101100130025 Homo sapiens METTL18 gene Proteins 0.000 description 1
- 229910021578 Iron(III) chloride Inorganic materials 0.000 description 1
- 150000000994 L-ascorbates Chemical class 0.000 description 1
- GFTKVOMEANZUPE-BBMIDSLUSA-J O.O.[Na+].[Na+].[Na+].[Na+].OC[C@H](O)[C@H]1OC(=O)C(OP([O-])(=O)OP([O-])(=O)OP(O)([O-])=O)=C1[O-] Chemical compound O.O.[Na+].[Na+].[Na+].[Na+].OC[C@H](O)[C@H]1OC(=O)C(OP([O-])(=O)OP([O-])(=O)OP(O)([O-])=O)=C1[O-] GFTKVOMEANZUPE-BBMIDSLUSA-J 0.000 description 1
- ZLMJMSJWJFRBEC-UHFFFAOYSA-N Potassium Chemical compound [K] ZLMJMSJWJFRBEC-UHFFFAOYSA-N 0.000 description 1
- 241000288906 Primates Species 0.000 description 1
- 240000004808 Saccharomyces cerevisiae Species 0.000 description 1
- 206010047623 Vitamin C deficiency Diseases 0.000 description 1
- MXHJVDWSCKZRBX-YCWPWOODSA-N [(2r)-2-[(1s)-1,2-dihydroxyethyl]-3-hydroxy-5-oxo-2h-furan-4-yl] [hydroxy(phosphonooxy)phosphoryl] hydrogen phosphate;dihydrate Chemical compound O.O.OC[C@H](O)[C@H]1OC(=O)C(OP(O)(=O)OP(O)(=O)OP(O)(O)=O)=C1O MXHJVDWSCKZRBX-YCWPWOODSA-N 0.000 description 1
- DZCCNVQWGRCKKG-NLBXRHDGSA-I [Na+].[Na+].[Na+].[Na+].[Na+].OC[C@H](O)[C@H]1OC(=O)C(OP([O-])(=O)OP([O-])(=O)OP([O-])([O-])=O)=C1[O-] Chemical compound [Na+].[Na+].[Na+].[Na+].[Na+].OC[C@H](O)[C@H]1OC(=O)C(OP([O-])(=O)OP([O-])(=O)OP([O-])([O-])=O)=C1[O-] DZCCNVQWGRCKKG-NLBXRHDGSA-I 0.000 description 1
- 238000002835 absorbance Methods 0.000 description 1
- 239000008351 acetate buffer Substances 0.000 description 1
- 238000005903 acid hydrolysis reaction Methods 0.000 description 1
- 150000007513 acids Chemical class 0.000 description 1
- 239000000654 additive Substances 0.000 description 1
- 229960005305 adenosine Drugs 0.000 description 1
- 239000003513 alkali Substances 0.000 description 1
- 150000008044 alkali metal hydroxides Chemical class 0.000 description 1
- 229910000147 aluminium phosphate Inorganic materials 0.000 description 1
- 150000001412 amines Chemical class 0.000 description 1
- 239000000908 ammonium hydroxide Substances 0.000 description 1
- 150000001450 anions Chemical class 0.000 description 1
- 230000003042 antagnostic effect Effects 0.000 description 1
- 239000012736 aqueous medium Substances 0.000 description 1
- 239000003125 aqueous solvent Substances 0.000 description 1
- 125000003289 ascorbyl group Chemical group [H]O[C@@]([H])(C([H])([H])O*)[C@@]1([H])OC(=O)C(O*)=C1O* 0.000 description 1
- 125000004429 atom Chemical group 0.000 description 1
- 238000006701 autoxidation reaction Methods 0.000 description 1
- 238000005842 biochemical reaction Methods 0.000 description 1
- 230000000903 blocking effect Effects 0.000 description 1
- 239000008280 blood Substances 0.000 description 1
- 210000004369 blood Anatomy 0.000 description 1
- 244000309464 bull Species 0.000 description 1
- BVKZGUZCCUSVTD-UHFFFAOYSA-N carbonic acid Chemical group OC(O)=O BVKZGUZCCUSVTD-UHFFFAOYSA-N 0.000 description 1
- 125000002091 cationic group Chemical group 0.000 description 1
- 239000001913 cellulose Substances 0.000 description 1
- 229920002678 cellulose Polymers 0.000 description 1
- 239000013522 chelant Substances 0.000 description 1
- 238000011097 chromatography purification Methods 0.000 description 1
- 239000011248 coating agent Substances 0.000 description 1
- 238000000576 coating method Methods 0.000 description 1
- 229910052802 copper Inorganic materials 0.000 description 1
- 239000010949 copper Substances 0.000 description 1
- 125000004122 cyclic group Chemical group 0.000 description 1
- 125000000753 cycloalkyl group Chemical group 0.000 description 1
- 230000018044 dehydration Effects 0.000 description 1
- 238000006297 dehydration reaction Methods 0.000 description 1
- 239000003814 drug Substances 0.000 description 1
- 238000000921 elemental analysis Methods 0.000 description 1
- 238000009585 enzyme analysis Methods 0.000 description 1
- 238000001704 evaporation Methods 0.000 description 1
- 230000008020 evaporation Effects 0.000 description 1
- 230000007717 exclusion Effects 0.000 description 1
- 230000037406 food intake Effects 0.000 description 1
- 244000144993 groups of animals Species 0.000 description 1
- XLYOFNOQVPJJNP-ZSJDYOACSA-N heavy water Substances [2H]O[2H] XLYOFNOQVPJJNP-ZSJDYOACSA-N 0.000 description 1
- GPRLSGONYQIRFK-UHFFFAOYSA-N hydron Chemical group [H+] GPRLSGONYQIRFK-UHFFFAOYSA-N 0.000 description 1
- 230000005764 inhibitory process Effects 0.000 description 1
- 229910052500 inorganic mineral Inorganic materials 0.000 description 1
- 238000005342 ion exchange Methods 0.000 description 1
- 238000004255 ion exchange chromatography Methods 0.000 description 1
- 150000002500 ions Chemical class 0.000 description 1
- 229910052742 iron Inorganic materials 0.000 description 1
- RBTARNINKXHZNM-UHFFFAOYSA-K iron trichloride Chemical compound Cl[Fe](Cl)Cl RBTARNINKXHZNM-UHFFFAOYSA-K 0.000 description 1
- 125000000654 isopropylidene group Chemical group C(C)(C)=* 0.000 description 1
- 230000007774 longterm Effects 0.000 description 1
- 159000000003 magnesium salts Chemical class 0.000 description 1
- 238000004519 manufacturing process Methods 0.000 description 1
- 239000002609 medium Substances 0.000 description 1
- 229910021645 metal ion Inorganic materials 0.000 description 1
- 150000004702 methyl esters Chemical class 0.000 description 1
- 239000011707 mineral Substances 0.000 description 1
- 150000007522 mineralic acids Chemical class 0.000 description 1
- MEFBJEMVZONFCJ-UHFFFAOYSA-N molybdate Chemical compound [O-][Mo]([O-])(=O)=O MEFBJEMVZONFCJ-UHFFFAOYSA-N 0.000 description 1
- 235000016709 nutrition Nutrition 0.000 description 1
- 150000007524 organic acids Chemical class 0.000 description 1
- 239000007800 oxidant agent Substances 0.000 description 1
- 238000010979 pH adjustment Methods 0.000 description 1
- ZSBGSQHBWLTTMB-NLBXRHDGSA-N pentaazanium [[[(2R)-2-[(1S)-1,2-dihydroxyethyl]-3-oxido-5-oxo-2H-furan-4-yl]oxy-oxidophosphoryl]oxy-oxidophosphoryl] phosphate Chemical compound P([O-])(=O)(OP(=O)([O-])OP(=O)([O-])[O-])OC=1C(=O)O[C@@H](C1[O-])[C@@H](O)CO.[NH4+].[NH4+].[NH4+].[NH4+].[NH4+] ZSBGSQHBWLTTMB-NLBXRHDGSA-N 0.000 description 1
- 230000000737 periodic effect Effects 0.000 description 1
- 230000000144 pharmacologic effect Effects 0.000 description 1
- 125000001997 phenyl group Chemical group [H]C1=C([H])C([H])=C(*)C([H])=C1[H] 0.000 description 1
- CKRORYDHXIRZCH-UHFFFAOYSA-N phosphoric acid;dihydrate Chemical compound O.O.OP(O)(O)=O CKRORYDHXIRZCH-UHFFFAOYSA-N 0.000 description 1
- 229920000642 polymer Polymers 0.000 description 1
- OQZCJRJRGMMSGK-UHFFFAOYSA-M potassium metaphosphate Chemical compound [K+].[O-]P(=O)=O OQZCJRJRGMMSGK-UHFFFAOYSA-M 0.000 description 1
- 229940099402 potassium metaphosphate Drugs 0.000 description 1
- 238000001556 precipitation Methods 0.000 description 1
- 230000001681 protective effect Effects 0.000 description 1
- UMJSCPRVCHMLSP-UHFFFAOYSA-N pyridine Natural products COC1=CC=CN=C1 UMJSCPRVCHMLSP-UHFFFAOYSA-N 0.000 description 1
- 239000012429 reaction media Substances 0.000 description 1
- 230000001105 regulatory effect Effects 0.000 description 1
- 208000010233 scurvy Diseases 0.000 description 1
- 238000000926 separation method Methods 0.000 description 1
- 229910000029 sodium carbonate Inorganic materials 0.000 description 1
- GCLGEJMYGQKIIW-UHFFFAOYSA-H sodium hexametaphosphate Chemical compound [Na]OP1(=O)OP(=O)(O[Na])OP(=O)(O[Na])OP(=O)(O[Na])OP(=O)(O[Na])OP(=O)(O[Na])O1 GCLGEJMYGQKIIW-UHFFFAOYSA-H 0.000 description 1
- 235000019982 sodium hexametaphosphate Nutrition 0.000 description 1
- 159000000000 sodium salts Chemical class 0.000 description 1
- 239000002904 solvent Substances 0.000 description 1
- 238000005507 spraying Methods 0.000 description 1
- 238000010186 staining Methods 0.000 description 1
- 239000000758 substrate Substances 0.000 description 1
- 239000000725 suspension Substances 0.000 description 1
- 230000002459 sustained effect Effects 0.000 description 1
- 238000013268 sustained release Methods 0.000 description 1
- 239000012730 sustained-release form Substances 0.000 description 1
- 238000003786 synthesis reaction Methods 0.000 description 1
- 239000001577 tetrasodium phosphonato phosphate Substances 0.000 description 1
- 230000001988 toxicity Effects 0.000 description 1
- 231100000419 toxicity Toxicity 0.000 description 1
- 150000003626 triacylglycerols Chemical class 0.000 description 1
- PBSRSWFGYPZDAU-FFIPNUABSA-H trimagnesium;[(2r)-2-[(1s)-1,2-dihydroxyethyl]-3-oxido-5-oxo-2h-furan-4-yl] phosphate Chemical compound [Mg+2].[Mg+2].[Mg+2].OC[C@H](O)[C@H]1OC(=O)C(OP([O-])([O-])=O)=C1[O-].OC[C@H](O)[C@H]1OC(=O)C(OP([O-])([O-])=O)=C1[O-] PBSRSWFGYPZDAU-FFIPNUABSA-H 0.000 description 1
- AIJAJGQAPNYWOW-UHFFFAOYSA-N tris(3-nitrophenyl) phosphate Chemical compound [O-][N+](=O)C1=CC=CC(OP(=O)(OC=2C=C(C=CC=2)[N+]([O-])=O)OC=2C=C(C=CC=2)[N+]([O-])=O)=C1 AIJAJGQAPNYWOW-UHFFFAOYSA-N 0.000 description 1
- 238000002211 ultraviolet spectrum Methods 0.000 description 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07F—ACYCLIC, CARBOCYCLIC OR HETEROCYCLIC COMPOUNDS CONTAINING ELEMENTS OTHER THAN CARBON, HYDROGEN, HALOGEN, OXYGEN, NITROGEN, SULFUR, SELENIUM OR TELLURIUM
- C07F9/00—Compounds containing elements of Groups 5 or 15 of the Periodic Table
- C07F9/02—Phosphorus compounds
- C07F9/547—Heterocyclic compounds, e.g. containing phosphorus as a ring hetero atom
- C07F9/655—Heterocyclic compounds, e.g. containing phosphorus as a ring hetero atom having oxygen atoms, with or without sulfur, selenium, or tellurium atoms, as the only ring hetero atoms
- C07F9/65515—Heterocyclic compounds, e.g. containing phosphorus as a ring hetero atom having oxygen atoms, with or without sulfur, selenium, or tellurium atoms, as the only ring hetero atoms the oxygen atom being part of a five-membered ring
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
- A61P3/02—Nutrients, e.g. vitamins, minerals
Landscapes
- Chemical & Material Sciences (AREA)
- Health & Medical Sciences (AREA)
- Organic Chemistry (AREA)
- Life Sciences & Earth Sciences (AREA)
- General Health & Medical Sciences (AREA)
- Biochemistry (AREA)
- Molecular Biology (AREA)
- Obesity (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Diabetes (AREA)
- Hematology (AREA)
- Nutrition Science (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Medicinal Chemistry (AREA)
- Engineering & Computer Science (AREA)
- Pharmacology & Pharmacy (AREA)
- Animal Behavior & Ethology (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Coloring Foods And Improving Nutritive Qualities (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Fodder In General (AREA)
Applications Claiming Priority (4)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US74908185 | 1985-06-25 | ||
US06/749,081 US4647672A (en) | 1985-06-25 | 1985-06-25 | Ascorbate 2-polyphosphate esters and method of making same |
US8601299 | 1986-06-18 | ||
PCT/US1986/001299 WO1987000172A1 (en) | 1985-06-25 | 1986-06-18 | Ascorbate 2-polyphosphate esters and method of making same |
Publications (3)
Publication Number | Publication Date |
---|---|
DK92987D0 DK92987D0 (da) | 1987-02-24 |
DK92987A DK92987A (da) | 1987-02-24 |
DK170283B1 true DK170283B1 (da) | 1995-07-24 |
Family
ID=25012170
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
DK092987A DK170283B1 (da) | 1985-06-25 | 1987-02-24 | Ascorbat-2-polyphosphatforbindelser og fremgangsmåde til deres fremstilling |
Country Status (13)
Country | Link |
---|---|
US (1) | US4647672A (fi) |
EP (1) | EP0229154B1 (fi) |
JP (1) | JPS63500240A (fi) |
CA (1) | CA1246593A (fi) |
DE (1) | DE3676671D1 (fi) |
DK (1) | DK170283B1 (fi) |
ES (1) | ES8707220A1 (fi) |
FI (1) | FI82835C (fi) |
IN (1) | IN163317B (fi) |
IS (1) | IS1304B6 (fi) |
PH (1) | PH22988A (fi) |
SG (1) | SG56193G (fi) |
WO (1) | WO1987000172A1 (fi) |
Families Citing this family (21)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US4814192A (en) * | 1987-11-18 | 1989-03-21 | The United States Of America As Represented By The Secretary Of Agriculture | Process for preserving raw fruits and vegetables using ascorbic acid esters |
US4975293A (en) * | 1988-01-11 | 1990-12-04 | The United States Of America As Represented By The Secretary Of Agriculture | Process for preserving raw fruit and vegetable juices using cyclodextrins and compositions thereof |
JP2747001B2 (ja) * | 1989-04-18 | 1998-05-06 | 昭和電工株式会社 | L―アスコルビン酸―2―リン酸エステル類の製造法 |
UA19385A1 (uk) * | 1989-04-27 | 1997-12-25 | Сендзю Фармасьютікал Ко. Лтд. | Фофоліпідhі похідhі та композиція, яка має аhтиоксидаhтhу та іhгібуючу активhість щодо пероксидів ліпідів |
US5118817A (en) * | 1989-10-31 | 1992-06-02 | Takeda Chemical Industries, Ltd. | Process for production of 2-phosphated esters of ascorbic acid |
US5149829A (en) * | 1991-01-14 | 1992-09-22 | Hoffmann-La Roche Inc. | Method of preparing dry, concentrated salts of ascorbate 2-polyphosphate |
DK0508233T3 (da) * | 1991-04-10 | 1996-09-16 | Hoffmann La Roche | Fremgangsmåde til fremstilling af ascorbinsyre-2-monophosphater ved tørring |
US5110950A (en) * | 1991-06-12 | 1992-05-05 | Kansas State University Research Foundation | Method of preparing 2-phosphorylated compounds of ascorbic acid |
WO1994000595A1 (en) * | 1992-06-25 | 1994-01-06 | Diversey Corporation | Phosphate analysis |
CN1208041A (zh) * | 1995-11-28 | 1999-02-17 | 北京市潮白河新技术研究所 | 抗坏血酸衍生物 |
US5937790A (en) * | 1996-12-18 | 1999-08-17 | Showa Denko Kabushiki Kaisha | Anti-stress agent for animals and a method of reducing stress in animals |
CA2230774C (en) * | 1997-03-18 | 2007-06-26 | F. Hoffmann-La Roche Ag | Manufacture of ascorbyl monophosphates |
DE19831056A1 (de) * | 1998-07-13 | 2000-01-20 | Basf Ag | Verfahren zur Herstellung von Salzen von Ascorbyl-2-phosphorsäureestern |
ATE228525T1 (de) | 1999-06-07 | 2002-12-15 | Hoffmann La Roche | Verfahren zur reinigung l-ascorbyl 2-monophosphat |
US7704515B2 (en) * | 2002-04-02 | 2010-04-27 | Ganado Research, L.L.C. | Composition and method to improve quality and yield of meat products |
EP1659879A1 (en) * | 2003-09-02 | 2006-05-31 | DSM IP Assets B.V. | Method of stabilizing ascorbyl phosphate and salts thereof |
US8275866B2 (en) * | 2007-11-13 | 2012-09-25 | At&T Intellectual Property I, L.P. | Assigning telecommunications nodes to community of interest clusters |
PL2948003T3 (pl) | 2013-01-23 | 2021-01-25 | Bottled Science Limited | Kompozycja napoju poprawiająca skórę |
CN103396442B (zh) * | 2013-08-21 | 2015-09-09 | 安徽天寅生物技术有限公司 | 水溶性维生素c偏磷酸钠钙及其制备方法 |
CN103554070A (zh) * | 2013-11-08 | 2014-02-05 | 李玉成 | 抗坏血酸氧铋、其制备方法及应用 |
EP3150067A4 (en) * | 2014-05-30 | 2017-11-08 | SBI Pharmaceuticals Co., Ltd. | Organ preservation solution |
Family Cites Families (1)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US4179445A (en) * | 1976-05-06 | 1979-12-18 | Kansas State University Research Foundation | Method of preparation of 2-phosphate esters of ascorbic acid |
-
1985
- 1985-06-25 US US06/749,081 patent/US4647672A/en not_active Expired - Lifetime
-
1986
- 1986-06-11 IS IS3109A patent/IS1304B6/is unknown
- 1986-06-11 IN IN449/MAS/86A patent/IN163317B/en unknown
- 1986-06-12 CA CA000511388A patent/CA1246593A/en not_active Expired
- 1986-06-18 WO PCT/US1986/001299 patent/WO1987000172A1/en active IP Right Grant
- 1986-06-18 DE DE8686904521T patent/DE3676671D1/de not_active Expired - Lifetime
- 1986-06-18 JP JP61503565A patent/JPS63500240A/ja active Granted
- 1986-06-18 EP EP86904521A patent/EP0229154B1/en not_active Expired - Lifetime
- 1986-06-24 ES ES556503A patent/ES8707220A1/es not_active Expired
- 1986-06-24 PH PH33940A patent/PH22988A/en unknown
-
1987
- 1987-02-23 FI FI870763A patent/FI82835C/fi not_active IP Right Cessation
- 1987-02-24 DK DK092987A patent/DK170283B1/da not_active IP Right Cessation
-
1993
- 1993-05-03 SG SG561/93A patent/SG56193G/en unknown
Also Published As
Publication number | Publication date |
---|---|
FI82835C (fi) | 1991-04-25 |
ES8707220A1 (es) | 1987-07-16 |
US4647672A (en) | 1987-03-03 |
FI82835B (fi) | 1991-01-15 |
DK92987D0 (da) | 1987-02-24 |
WO1987000172A1 (en) | 1987-01-15 |
EP0229154B1 (en) | 1990-12-27 |
IN163317B (fi) | 1988-09-03 |
PH22988A (en) | 1989-02-24 |
FI870763A (fi) | 1987-02-23 |
IS3109A7 (is) | 1986-12-26 |
EP0229154A1 (en) | 1987-07-22 |
CA1246593A (en) | 1988-12-13 |
DK92987A (da) | 1987-02-24 |
JPH0521114B2 (fi) | 1993-03-23 |
EP0229154A4 (en) | 1987-10-06 |
JPS63500240A (ja) | 1988-01-28 |
SG56193G (en) | 1993-07-09 |
FI870763A0 (fi) | 1987-02-23 |
ES556503A0 (es) | 1987-07-16 |
IS1304B6 (is) | 1987-11-25 |
DE3676671D1 (de) | 1991-02-07 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
DK170283B1 (da) | Ascorbat-2-polyphosphatforbindelser og fremgangsmåde til deres fremstilling | |
Frick et al. | Transition state stabilization by deaminases: rates of nonenzymatic hydrolysis of adenosine and cytidine | |
AU727119B2 (en) | Manufacture of ascorbyl monophosphates | |
JPH10298174A (ja) | アスコルビン酸誘導体及びそれを含有するビタミンc剤 | |
JPS61171491A (ja) | イノシト−ルトリホスフエ−ト及びその製造方法 | |
US6121464A (en) | Preparation of salts of ascorbyl 2-phosphoric esters | |
EP0138558A2 (en) | Phospholipids and their production and use | |
EP0884321B1 (en) | Ascorbic acid 2-phosphate zinc salt and process for manufacturing the same | |
JPH041759B2 (fi) | ||
EP1409494B1 (en) | Stabilized derivatives of ascorbic acid -3- phosphate | |
JPS594438B2 (ja) | アスコルビン酸の燐酸エステルの製法 | |
NO170761B (no) | Askorbat-2-polyfosfatforbindelser og fremgangsmaate til fremstilling derav | |
CN101775032A (zh) | 氯硝柳胺磷酸酯、其药学上可接受的盐及其应用 | |
EP0306904B1 (en) | Phosphoric acid diesters and salts thereof | |
JPWO2003010172A1 (ja) | 高純度リボフラビン−5’−リン酸ナトリウム塩の製造方法 | |
CN101974034A (zh) | 黄酮磷酸烷酯类化合物的合成和在胆固醇酯酶抑制剂药物中的应用 | |
SE430507B (sv) | Forfarande for framstellning av ett 9-hydroxietoximetyl-guaninderivat | |
JP2004217555A (ja) | クルミの仁由来のポリフェノール | |
KR910008733B1 (ko) | L-아스코르빈산-2-인산에스테르 마그네슘염의 제조방법 | |
EP1059298B1 (en) | Process for purifying L-ascorbyl 2-monophosphate | |
CN108285470B (zh) | 一种合成维生素c磷酸酯镁的方法 | |
JPWO2018021542A1 (ja) | 2−O−α−D−グリコシル−L−アスコルビン酸金属塩、その酸化防止剤としての用途及びその粉末の製造方法 | |
WO2016147185A1 (en) | Adenosine thiophosphate derivatives and uses thereof | |
KR20030046269A (ko) | 엘-아스코빌-2-인산에스테르마그네슘의 제조방법 | |
CN114105986A (zh) | 一种芳香稠环二酮类化合物及其制备方法与应用 |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
PBP | Patent lapsed |
Country of ref document: DK |